MSA
CORT icon

Mason Street Advisors’s Corcept Therapeutics CORT Stock Holding History

Mason Street Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-38,989
Closed -$1.02M – 281
2020
Q4 		$1.02M Sell
38,989
-30
-0.1% -$632 0.02% 921
2020
Q3 		$679K Buy
39,019
+297
+0.8% +$4.73K 0.01% 986
2020
Q2 		$651K Buy
38,722
+2,898
+8% +$40.7K 0.01% 984
2020
Q1 		$426K Hold
35,824
– – 0.01% 1045
2019
Q4 		$433K Buy
35,824
+1,081
+3% +$15K 0.01% 1181
2019
Q3 		$491K Sell
34,743
-146
-0.4% -$1.79K 0.01% 1107
2019
Q2 		$389K Buy
34,889
+1,361
+4% +$15.2K 0.01% 1176
2019
Q1 		$394K Buy
33,528
+895
+3% +$11.1K 0.01% 1209
2018
Q4 		$436K Buy
32,633
+1,341
+4% +$17.7K 0.01% 1080
2018
Q3 		$439K Buy
31,292
+3,672
+13% +$51.3K 0.01% 1151
2018
Q2 		$434K Buy
27,620
+1,180
+4% +$20.5K 0.01% 1127
2018
Q1 		$435K Buy
26,440
+4,661
+21% +$86.4K 0.01% 1087
2017
Q4 		$393K Buy
+21,779
New +$394K 0.01% 1111

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mason Street Advisors's CORT Position: Q1 2021 in Review

Mason Street Advisors sold out of Corcept Therapeutics (CORT) in Q1 2021, closing a stake of 38,989 shares — an estimated $1.02M sold.

Mason Street Advisors first reported a position in CORT in Q4 2017 and held it in 13 quarters. The position peaked at $1.02M in Q4 2020. 209 funds tracked by Wall St. Rank hold CORT as of Q1 2021.

  • Mason Street Advisors reported no remaining Corcept Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 38,989 Corcept Therapeutics shares in Q1 2021, an estimated $1.02M.
  • Mason Street Advisors first reported a position in Corcept Therapeutics in Q4 2017 and held it in 13 quarters.
  • Mason Street Advisors's Corcept Therapeutics position peaked at $1.02M in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.